Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > The offering -- Sedar
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1176)
•••
Comment by Pandoraon Oct 14, 2021 1:42pm
191 Views
Post# 34006026

RE:The offering -- Sedar

RE:The offering -- Sedar
Ontario
Securities
Commission
Commission des
valeurs mobilires
de l’Ontario
22nd Floor
20 Queen Street West
Toronto ON M5H 3S8
22e tage
20, rue Queen ouest
Toronto ON M5H 3S8
RECEIPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
This is the receipt of the Ontario Securities Commission for the Short Form Prospectus of the above Issuer
dated October 13, 2021 (the prospectus).
The prospectus has been filed under Multilateral Instrument 11-102 Passport System in Alberta, British
Columbia and Saskatchewan. A receipt for the prospectus is deemed to be issued by the regulator in each of
those jurisdictions, if the conditions of the Instrument have been satisfied.
October 14, 2021
Sonny Randhawa
Sonny Randhawa
Director, Corporate Finance Branch
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities